AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
U.S. Trial Starts For Recombinant Human Albumin Vaccines.(Brief Article)
2002 JAN 9 - (NewsRx.com & NewsRx.net) -- Merck's investigational new drug application (IND) for this vaccine became effective in December 2001 and the preparations for the pivotal clinical trial are complete. This therapeutic development results from collaborative efforts between Delta and Merck to define and test the use of Delta's recombinant albumin in the measles, mumps and rubella vaccine production process.
Merck's investigational measles, mumps and rubella vaccine will be the first product in a pivotal U.S. clinical trial containing Recombumin and may represent an important milestone in the ...
- ADVISORY/Aventis Behring L.L.C. Announces Successful Results of Large, Pivotal...
- Press release article from: Business Wire October 4, 2000 700+ words
...announced the successful results of its large, pivotal Phase I clinical trial for Recombumin(R) 20 percent. The trial was designed to assess the tolerability of Recombumin(R) 20 percent as a stabilizing component in pharmaceutical and biological...
- ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use...
- Press release article from: PR Newswire December 3, 2008 700+ words
...supply its recombinant human albumin, Recombumin(R), for the continued development...Novozymes Biopharma will also supply Recombumin(R) or other recombinant albumin products...amp; CEO of ConjuChem stated, "Recombumin(R) is an important part of our current...
- Delta Biotechnology's New Protein Technology Adopted by Merck for...
- Press release article from: Business Wire December 18, 2001 700+ words
...Trial for Product Using Recombumin(R)- Delta Biotechnology, Ltd...Developed and manufactured by Delta Biotechnology, Recombumin(R) is a protein structurally...dramatically increased demand for Recombumin(R), Delta recently began exploring...
- CENTEON ACQUIRES DELTA BIOTECHNOLOGY; PLATFORM FOR RECOMBINANT PRODUCT LINE...
- Press release article from: PR Newswire May 20, 1996 700+ words
...therapeutic use for rHA. "The Delta acquisition brings us a pipeline...patients throughout the world." Delta has trademark rights for the rHA product names Recombumin(R) and Albugen(R). Delta's state-of-the-art production...
- ProMetic Announces Technology Utilized to Develop a New Level of Purity in...
- Press release article from: PR Newswire January 22, 2001 700+ words
...biological products. Recombumin(R)20% is produced by Delta Biotechnology Limited...Behring L.L.C. Recombumin(R)20% is expressed...Aventis Behring's Delta Biotechnology Ltd. "Recombumin(R)20% symbolizes...
- Aventis Behring Announces Successful Results for First Recombinant Albumin...
- Press release article from: Business Wire October 4, 2000 700+ words
...biological products can use Recombumin(R)20% as a stabilizing...existing products. Delta Biotechnology Ltd...already producing Recombumin(R)20% in small...General Manager of Delta Biotechnology Ltd. "Recombumin(R)20% symbolizes...
- Ohmeda announces sale of biotechnology unit to plasma products company.
- Press release article from: Business Wire May 20, 1996 700+ words
...acute care pharmaceuticals." "The Delta acquisition brings us a pipeline...patients throughout the world." Delta has trademark rights for the rHA product names Recombumin(R) and Albugen(R). Delta's state-of-the-art production...
- Novozymes Getting Protein Production, More From Delta.
- Magazine article from: BIOWORLD Today Pihl-Carey, Karen July 10, 2006 700+ words
...antimicrobial peptides. Delta's business involves...commercialized product, Recombumin, the world's first...director of Novozymes Delta, "and with Novozymes...market." Aside from Recombumin, the company is developing...
Source: HighBeam Research, U.S. Trial Starts For Recombinant Human Albumin Vaccines.(Brief...